Examination Report |
1 | Power of Attorney | 15 Feb 2017 |
2 | TM-1 | 15 Feb 2017 |
3 | Reply to Exam Report (MIS-R) | 19 Jul 2017 |
4 | Reply to Exam Report (MIS-R) | 03 Apr 2019 |
5 | Journal Copy | 09 Feb 2021 |
6 | Certificate | 23 Jun 2021 |
1 | Dispatching of Examination Report for : 3484309 via Email | 4888072 | 2124032 | 27 Jun 2017 |
2 | Hearing Notice (Show Cause) | 9107785 | 4502163 | 17 Oct 2019 |
3 | Hearing notice (Adjourned) | 9834345 | 4853210 | 27 Feb 2020 |
4 | Hearing Notice (Show Cause) | 10764969 | 03 Dec 2020 | |
5 | Tribunal Accepted Notice for : 3484309 | 11023549 | 5091738 | 27 Jan 2021 |
Trademark was applied on 15 February 2017 with IP India.
Proprietor of Ibmide is INDIABULLS PHARMACEUTICALS.
Class(es) in which the trademark was applied to is 5.
Status of Ibmide is Registered.
Application number alloted to the trademark is 3484309.
Singh & Singh Lall & Sethi is the Trademark agent/attorney.
Trademark has been filed in the following category:
WORD